← Back to Search

Optical Sensor

Optical Sensor Detection for Oral Diseases

N/A
Recruiting
Led By Petra Wilder-Smith, DDS,PhD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have condition of Gum disease
Have condition of dry mouth
Must not have
Age less than 18 years old
Advanced gum disease, diseases of oral tissue
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking to develop better ways of detecting, diagnosing and measuring oral diseases and structures using light and optical approaches.

Who is the study for?
This trial is for adults over 18, both smokers and non-smokers, with various oral conditions like dry mouth, gum disease, or lesions. It's also open to healthy individuals as controls. People under 18, those with advanced gum disease or untreated cavities, pregnant or breastfeeding women, and immune-compromised individuals cannot participate.
What is being tested?
The study aims to develop a new non-invasive method using light-based technologies to detect and diagnose oral diseases. Techniques include Coherence Tomography, Laser Speckle Imaging, Spectroscopy and Fluorescence compared against traditional clinical evaluations.
What are the potential side effects?
Since the interventions involve non-invasive imaging techniques without radiation exposure or physical intrusion into the body tissues there are no significant side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have gum disease.
Select...
I have dry mouth.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I have severe gum or oral tissue disease.
Select...
I have cavities that haven't been treated.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Healthy oral tissue

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Oral tissueExperimental Treatment1 Intervention
Imaging of oral structures and pathologies

Find a Location

Who is running the clinical trial?

Livionex Inc.Industry Sponsor
3 Previous Clinical Trials
308 Total Patients Enrolled
Beckman Laser Institute University of California IrvineOTHER
77 Previous Clinical Trials
2,443 Total Patients Enrolled
OrahealthUNKNOWN
Livionex IncUNKNOWN
2 Previous Clinical Trials
197 Total Patients Enrolled
University of California, IrvineLead Sponsor
566 Previous Clinical Trials
1,930,548 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,840 Previous Clinical Trials
8,170,120 Total Patients Enrolled
National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
95 Previous Clinical Trials
18,803 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,957 Previous Clinical Trials
41,109,580 Total Patients Enrolled
National Institute of Dental and Craniofacial Research (NIDCR)NIH
308 Previous Clinical Trials
847,776 Total Patients Enrolled
2 Trials studying Oral Diseases
793 Patients Enrolled for Oral Diseases
Petra Wilder-Smith, DDS,PhDPrincipal InvestigatorBeckman Laser Institute, University of Calfornia Irvine

Media Library

Detection of Oral Pathology (Optical Sensor) Clinical Trial Eligibility Overview. Trial Name: NCT00540774 — N/A
Oral Diseases Research Study Groups: Oral tissue
Oral Diseases Clinical Trial 2023: Detection of Oral Pathology Highlights & Side Effects. Trial Name: NCT00540774 — N/A
Detection of Oral Pathology (Optical Sensor) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00540774 — N/A
~381 spots leftby Dec 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top